Description
A potent and selective ERβ agonist (IC50s = 2 and 187 nM for human full-length ERβ and ERα, respectively); induces nuclear translocation of ERβ and increases c-fos activation and dopamine levels in the striatum four hours after administration; decreases depressive-like behaviors and has anxiolytic effects in mice; improves glucose and insulin sensitivity in mouse models of diabetes,
Formal name: 7-bromo-2-(4-hydroxyphenyl)-5-benzoxazolol
Synonyms: WAY-00005
Molecular weight: 306.1
CAS: 440122-66-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Estrogens & Progestins||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Neuroscience|Behavioral Neuroscience|Anxiety||Research Area|Neuroscience|Behavioral Neuroscience|Depression